Skip to main content
. 2024 Jan 11;16(2):312. doi: 10.3390/cancers16020312

Table 1.

Antigen-processing (AP) components are downregulated with varying frequency in head and neck cancer (HNC). Studies on AP component expression alterations were performed on primary HNC samples and/or on HNC cell lines.

AP Component HNCs That Downregulate References
TAP1 34–71% [64,68,69,70,71]
TAP2 64–88% [64,68,70]
Tapasin 40–79% [64,68,69,71]
LMP2 78–88% [64,70,71]
LMP7 ~60% [64,70]
β2M 60–87% [64,71]
Calnexin ~34% [71]
Calreticulin ~19% [71]
ERp57 ~26% [71]